Login / Signup

Incidence and time course of neutropenia in patients treated with rituximab-based therapy for non-malignant immune-mediated hematologic diseases.

Luis E Malpica-CastilloShannon PalmerAnqi ZhuAllison M DealSheh-Li ChenStephan Moll
Published in: American journal of hematology (2020)
Keyphrases
  • diffuse large b cell lymphoma
  • risk factors
  • chronic lymphocytic leukemia
  • hodgkin lymphoma
  • chemotherapy induced